BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34294273)

  • 1. Percutaneous Coronary Revascularization: JACC Historical Breakthroughs in Perspective.
    Serruys PW; Ono M; Garg S; Hara H; Kawashima H; Pompilio G; Andreini D; Holmes DR; Onuma Y; King Iii SB
    J Am Coll Cardiol; 2021 Jul; 78(4):384-407. PubMed ID: 34294273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial Revascularization Surgery: JACC Historical Breakthroughs in Perspective.
    Mack MJ; Squiers JJ; Lytle BW; DiMaio JM; Mohr FW
    J Am Coll Cardiol; 2021 Jul; 78(4):365-383. PubMed ID: 34294272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous Coronary Intervention of Left Main Disease: Pre- and Post-EXCEL (Evaluation of XIENCE Everolimus Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) and NOBLE (Nordic-Baltic-British Left Main Revascularization Study) Era.
    Park DW; Park SJ
    Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28607000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
    Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
    J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease: a meta-analysis.
    Li X; Kong M; Jiang D; Dong A
    Interact Cardiovasc Thorac Surg; 2014 Mar; 18(3):347-54. PubMed ID: 24345688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Evolution of Coronary Bypass Surgery Will Determine Its Relevance as the Standard of Care for the Treatment for Multivessel Coronary Artery Disease.
    Glineur D; Gaudino M; Grau J
    Circulation; 2016 Oct; 134(17):1206-1208. PubMed ID: 27777289
    [No Abstract]   [Full Text] [Related]  

  • 7. The comparative efficacy of percutaneous and surgical coronary revascularization in 2009: a review.
    May SA; Wilson JM
    Tex Heart Inst J; 2009; 36(5):375-86. PubMed ID: 19876412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary artery bypass graft surgery versus percutaneous coronary intervention with first-generation drug-eluting stents: a meta-analysis of randomized controlled trials.
    Al Ali J; Franck C; Filion KB; Eisenberg MJ
    JACC Cardiovasc Interv; 2014 May; 7(5):497-506. PubMed ID: 24746647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a Simple Angiographic Approach With a Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Score-Based Approach for Left Main Coronary Artery Stenting: A Pooled Analysis of Serial PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease) Studies.
    Lee PH; Lee JY; Lee CW; Kim SO; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Park SJ
    Circ Cardiovasc Interv; 2018 Jan; 11(1):e005374. PubMed ID: 29311287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary artery bypass graft surgery versus percutaneous coronary intervention in unprotected left main coronary artery disease: A systematic review.
    Macovei L; Magopet R; Tanasa A; Raileanu C; Prisacariu C; Presura MR; Balasanian MO
    Rev Cardiovasc Med; 2020 Mar; 21(1):65-73. PubMed ID: 32259905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 40 Years of Percutaneous Coronary Intervention: A Historical Remark on the Development and Evolution of Guidewire Technology.
    Kaltenbach M
    JACC Cardiovasc Interv; 2017 Dec; 10(24):2582-2583. PubMed ID: 29268889
    [No Abstract]   [Full Text] [Related]  

  • 12. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
    Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.
    Sotomi Y; Cavalcante R; van Klaveren D; Ahn JM; Lee CW; de Winter RJ; Wykrzykowska JJ; Onuma Y; Steyerberg EW; Park SJ; Serruys PW
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1564-72. PubMed ID: 27491605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 40 Years of Percutaneous Coronary Intervention: A Historical Remark on the Development of the Monorail Technique.
    Bonzel T
    JACC Cardiovasc Interv; 2017 Dec; 10(24):2583-2584. PubMed ID: 29268890
    [No Abstract]   [Full Text] [Related]  

  • 15. Interventional Management of Unprotected Left Main Coronary Artery Disease: Patient Selection and Technique Optimization.
    Rizik DG; Klassen KJ; Burke RF; Hodgson JM; Stone GW
    J Interv Cardiol; 2015 Aug; 28(4):326-38. PubMed ID: 26077351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left Main Disease: What Is the Correct Approach to Revascularization?
    Rab T; King SB
    Cardiol Rev; 2018; 26(5):219-229. PubMed ID: 29794807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous Coronary Intervention or Surgery for Unprotected Left Main Disease: EXCEL Trial at 5 Years.
    Azzalini L; Stone GW
    Interv Cardiol Clin; 2020 Oct; 9(4):419-432. PubMed ID: 32921366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of percutaneous coronary intervention in the treatment of left main coronary artery disease.
    Kappetein AP; Head SJ; Osnabrugge RL; van Mieghem NM
    Semin Thorac Cardiovasc Surg; 2014; 26(3):187-91. PubMed ID: 25527012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.